2009
DOI: 10.1016/j.dld.2008.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Persistent elevation of serum CA 19-9 with no evidence of malignant disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
41
0
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(44 citation statements)
references
References 36 publications
1
41
0
1
Order By: Relevance
“…As noted earlier, CA 19-9 serum levels may be elevated in a variety of nonpancreatic neoplastic conditions resulting in a high false positive rate (10-30%). Benign conditions associated with elevated serum CA 19-9 levels include ovarian cyst, heart failure, hashimoto's thyroiditis, rheumatoid arthritis and diverticulitis [16][17][18][19][69][70][71][72][73][74] (Table 6). Marked elevations in CA 19-9 serum levels have also been reported in numerous benign and malignant biliary conditions .8%) such as choledocholithiasis, gall bladder cancer and cholangiocarcinoma.…”
Section: Limitations Of Ca 19-9 Serum Levels As a Pancreatic Cancer Bmentioning
confidence: 99%
See 1 more Smart Citation
“…As noted earlier, CA 19-9 serum levels may be elevated in a variety of nonpancreatic neoplastic conditions resulting in a high false positive rate (10-30%). Benign conditions associated with elevated serum CA 19-9 levels include ovarian cyst, heart failure, hashimoto's thyroiditis, rheumatoid arthritis and diverticulitis [16][17][18][19][69][70][71][72][73][74] (Table 6). Marked elevations in CA 19-9 serum levels have also been reported in numerous benign and malignant biliary conditions .8%) such as choledocholithiasis, gall bladder cancer and cholangiocarcinoma.…”
Section: Limitations Of Ca 19-9 Serum Levels As a Pancreatic Cancer Bmentioning
confidence: 99%
“…Marked elevations in CA 19-9 serum levels have also been reported in numerous benign and malignant biliary conditions .8%) such as choledocholithiasis, gall bladder cancer and cholangiocarcinoma. Finally, CA 19-9 serum levels alone cannot differentiate between benign, precursor lesions and malignant pancreatic conditions such as acute and chronic pancreatitis, intraductal pancreatic mucinous neoplasm (IPMN), pancreatic intra-epithelial neoplasia (PANIN) and pancreatic cancer as the former are also associated with elevated CA 19-9 serum levels in 10-50% of cases [69][70][71][72][73][74][75].…”
Section: Limitations Of Ca 19-9 Serum Levels As a Pancreatic Cancer Bmentioning
confidence: 99%
“…This case was of particular interest for the following reasons: first, the appearance of gastrointestinal symptoms, such as bloating, diarrhea and weight loss, due to the appearance of lactose intolerance [4]; second, the transient increase of CA 19-9 in celiac patients which was due to causes other than the presence of gastrointestinal cancer, which usually indicates in the general population [5], and third, capsule endoscopy was useful in detecting ileal mucosa abnormalities which disappear after going on a gluten-and cow milk-free diet.…”
Section: Discussionmentioning
confidence: 99%
“…CA 19-9 can increase in different benign conditions, including diverticular disease, as well (3,21).…”
Section: Afp and Ca 19-9 In Liver Pathologymentioning
confidence: 99%